Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 20
2012 27
2013 25
2014 23
2015 12
2016 29
2017 28
2018 57
2019 74
2020 89
2021 94
2022 79
2023 67
2024 33

Text availability

Article attribute

Article type

Publication date

Search Results

492 results

Results by year

Filters applied: . Clear all
Page 1
Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis.
Wenzel M, Nocera L, Collà Ruvolo C, Würnschimmel C, Tian Z, Shariat SF, Saad F, Tilki D, Graefen M, Kluth LA, Briganti A, Mandel P, Montorsi F, Chun FKH, Karakiewicz PI. Wenzel M, et al. Among authors: tian z. Prostate Cancer Prostatic Dis. 2022 Feb;25(2):139-148. doi: 10.1038/s41391-021-00395-4. Epub 2021 May 30. Prostate Cancer Prostatic Dis. 2022. PMID: 34054128 Free PMC article. Review.
Reply by Authors.
Wenzel M, Nocera L, Collà Ruvolo C, Würnschimmel C, Tian Z, Shariat SF, Saad F, Briganti A, Tilki D, Graefen M, Kluth LA, Mandel P, Chun FKH, Karakiewicz PI. Wenzel M, et al. Among authors: tian z. J Urol. 2021 Jul;206(1):79. doi: 10.1097/JU.0000000000001695.03. Epub 2021 Apr 6. J Urol. 2021. PMID: 33820427 No abstract available.
IO-IO vs IO-TKI efficacy in metastatic kidney cancer patients: A structured systematic review over time.
Hoeh B, Flammia RS, Hohenhorst L, Sorce G, Panunzio A, Tappero S, Tian Z, Saad F, Gallucci M, Briganti A, Terrone C, Shariat SF, Graefen M, Tilki D, Antonelli A, Kosiba M, Kluth LA, Becker A, Chun FKH, Karakiewicz PI. Hoeh B, et al. Among authors: tian z. Semin Oncol. 2022 Oct;49(5):394-399. doi: 10.1053/j.seminoncol.2022.10.001. Epub 2022 Oct 23. Semin Oncol. 2022. PMID: 36333148 Review.
Treatment of Ureteral Stent-Related Symptoms.
Pecoraro A, Peretti D, Tian Z, Aimar R, Niculescu G, Alleva G, Piana A, Granato S, Sica M, Amparore D, Checcucci E, Manfredi M, Karakiewicz P, Fiori C, Porpiglia F. Pecoraro A, et al. Among authors: tian z. Urol Int. 2023;107(3):288-303. doi: 10.1159/000518387. Epub 2021 Nov 2. Urol Int. 2023. PMID: 34818261 Free article.
Characteristics of incidental prostate cancer in the United States.
Scheipner L, Incesu RB, Morra S, Baudo A, Assad A, Jannello LMI, Siech C, de Angelis M, Barletta F, Tian Z, Saad F, Shariat SF, Briganti A, Chun FKH, Tilki D, Longo N, Carmignani L, De Cobelli O, Ahyai S, Karakiewicz PI. Scheipner L, et al. Among authors: tian z. Prostate Cancer Prostatic Dis. 2023 Oct 23. doi: 10.1038/s41391-023-00742-7. Online ahead of print. Prostate Cancer Prostatic Dis. 2023. PMID: 37872250
Cancer-specific Mortality After Cryoablation vs Heat-based Thermal Ablation in T1a Renal Cell Carcinoma.
Sorce G, Hoeh B, Hohenhorst L, Panunzio A, Tappero S, Tian Z, Kokorovic A, Larcher A, Capitanio U, Tilki D, Terrone C, Chun FKH, Antonelli A, Saad F, Shariat SF, Montorsi F, Briganti A, Karakiewicz PI. Sorce G, et al. Among authors: tian z. J Urol. 2023 Jan;209(1):81-88. doi: 10.1097/JU.0000000000002984. Epub 2022 Nov 28. J Urol. 2023. PMID: 36440817
Other-cause mortality in incidental prostate cancer.
Di Bello F, Baudo A, de Angelis M, Jannello LMI, Siech C, Tian Z, Goyal JA, Collà Ruvolo C, Califano G, La Rocca R, Morra S, Acquati P, Saad F, Shariat SF, Carmignani L, de Cobelli O, Briganti A, Chun FKH, Longo N, Karakiewicz PI. Di Bello F, et al. Among authors: tian z. Prostate. 2024 Mar 20. doi: 10.1002/pros.24689. Online ahead of print. Prostate. 2024. PMID: 38506561
492 results